Shuuichi Mori

736 total citations
21 papers, 569 citations indexed

About

Shuuichi Mori is a scholar working on Neurology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Shuuichi Mori has authored 21 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Shuuichi Mori's work include Myasthenia Gravis and Thymoma (9 papers), Antifungal resistance and susceptibility (7 papers) and Peripheral Neuropathies and Disorders (6 papers). Shuuichi Mori is often cited by papers focused on Myasthenia Gravis and Thymoma (9 papers), Antifungal resistance and susceptibility (7 papers) and Peripheral Neuropathies and Disorders (6 papers). Shuuichi Mori collaborates with scholars based in Japan, United States and Sweden. Shuuichi Mori's co-authors include Kazuhiro Shigemoto, Tsuyoshi Miyazaki, Hiroshi Nishimune, Shigeru Yamada, Sachiho Kubo, Naoki Maruyama, Masahiko Kishi, Kumpei Tokuyama, Yomna Badawi and Norihisa Ishii and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shuuichi Mori

19 papers receiving 557 citations

Peers

Shuuichi Mori

NEURO

SURGE

EPIDE

Annalisa Schirinzi Italy

Lukas Tombor Germany

Sophia M. Chung United States

Rafiqua Ben El Haj Morocco

Citlaltepetl Salinas‐Lara Mexico

David Heinzmann Germany

Samuel F. Passi United States

Zhaoxia Ma China

Qiuming Zeng China

Annalisa Schirinzi Italy

Shuuichi Mori

257 ×1.1

227 ×1.1

NEURO

68 ×0.5

44 ×0.5

SURGE

56 ×0.9

EPIDE

Citations per year, relative to Shuuichi Mori Shuuichi Mori (= 1×) peers Annalisa Schirinzi

Countries citing papers authored by Shuuichi Mori

Since Specialization

Citations

This map shows the geographic impact of Shuuichi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuuichi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuuichi Mori more than expected).

Fields of papers citing papers by Shuuichi Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuuichi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuuichi Mori. The network helps show where Shuuichi Mori may publish in the future.

Co-authorship network of co-authors of Shuuichi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Shuuichi Mori. A scholar is included among the top collaborators of Shuuichi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuuichi Mori. Shuuichi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mori, Shuuichi, et al.. (2025). Muscle-specific kinase levels in blood are an early diagnostic biomarker for SOD1-93A mouse model of ALS. Frontiers in Neurology. 16. 1556120–1556120.

Mori, Shuuichi, Shigeaki Suzuki, Tetsuro Konishi, et al.. (2022). Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis. Experimental Neurology. 361. 114300–114300. 1 indexed citations

Mori, Shuuichi, Takuya Omura, Yoshihiro Noda, et al.. (2021). Muscle fiber type specific alterations of mitochondrial respiratory function and morphology in aged female mice. Biochemical and Biophysical Research Communications. 540. 116–122. 10 indexed citations

Mori, Shuuichi & Kazuhiro Shigemoto. (2019). Utility of experimental animal models of myasthenia gravis for the elucidation of pathogenic mechanisms and development of new medications. Clinical and Experimental Neuroimmunology. 10(2). 85–95.

Motohashi, Norio, Akiyoshi Uezumi, Atsushi Asakura, et al.. (2018). Tbx1 regulates inherited metabolic and myogenic abilities of progenitor cells derived from slow- and fast-type muscle. Cell Death and Differentiation. 26(6). 1024–1036. 27 indexed citations

Mori, Shuuichi, et al.. (2017). Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis. Experimental Neurology. 297. 158–167. 22 indexed citations

Nishimune, Hiroshi, Yomna Badawi, Shuuichi Mori, & Kazuhiro Shigemoto. (2016). Dual-color STED microscopy reveals a sandwich structure of Bassoon and Piccolo in active zones of adult and aged mice. Scientific Reports. 6(1). 27935–27935. 56 indexed citations

Shigemoto, Kazuhiro, et al.. (2015). [Animal models of myasthenia gravis].. PubMed. 73 Suppl 7. 97–104. 1 indexed citations

Mori, Shuuichi, K. Koshi, & Kazuhiro Shigemoto. (2014). The important role of the neuromuscular junction in maintaining muscle mass and strength. SHILAP Revista de lepidopterología. 3(1). 111–114. 4 indexed citations

10.

Mori, Shuuichi & Kazuhiro Shigemoto. (2013). Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis. Autoimmunity Reviews. 12(9). 912–917. 31 indexed citations

11.

Miyazaki, Tsuyoshi, Mitsuyasu Iwasawa, Tomoki Nakashima, et al.. (2012). Intracellular and Extracellular ATP Coordinately Regulate the Inverse Correlation between Osteoclast Survival and Bone Resorption. Journal of Biological Chemistry. 287(45). 37808–37823. 107 indexed citations

12.

Mori, Shuuichi, Shigeru Yamada, Sachiho Kubo, et al.. (2012). Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis. Journal of Neuroimmunology. 244(1-2). 1–7. 37 indexed citations

13.

Mori, Shuuichi, Masahiko Kishi, Sachiho Kubo, et al.. (2012). 3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis. Journal of Neuroimmunology. 245(1-2). 75–78. 35 indexed citations

14.

Miyazaki, Tsuyoshi, Shuuichi Mori, Kazuhiro Shigemoto, et al.. (2012). Maintenance of mitochondrial DNA copy number is essential for osteoclast survival. Arthritis Research & Therapy. 14(S1). 3 indexed citations

15.

Mori, Shuuichi, Sachiho Kubo, Shigeru Yamada, et al.. (2011). Antibodies against Muscle-Specific Kinase Impair Both Presynaptic and Postsynaptic Functions in a Murine Model of Myasthenia Gravis. American Journal Of Pathology. 180(2). 798–810. 98 indexed citations

16.

Aoki, Kazutaka, Tomoyuki Iwasaki, Akinobu Nakamura, et al.. (2010). Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Metabolism. 60(5). 617–628. 56 indexed citations

17.

Suzuki, Koichi, et al.. (2009). Global leprosy situation, beginning of 2008. PubMed. 78(1). 25–34. 52 indexed citations

18.

Aoki, Kazutaka, Junji Matsui, Naoto Kubota, et al.. (2009). Role of the liver in glucose homeostasis in PI 3-kinase p85α-deficient mice. American Journal of Physiology-Endocrinology and Metabolism. 296(4). E842–E853. 10 indexed citations

19.

Mori, Shuuichi & Kumpei Tokuyama. (2007). ACE activity affects myogenic differentiation via mTOR signaling. Biochemical and Biophysical Research Communications. 363(3). 597–602. 9 indexed citations

20.

Mori, Shuuichi & Kumpei Tokuyama. (2006). Variation in ACE activity affects myogenic differentiation in C2C12 cells. Biochemical and Biophysical Research Communications. 353(2). 369–375. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact